Skip to main content
ホーム / ニュース / Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation

Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation

Certara improves software capabilities by expanding into deep learning and data fabric

PRINCETON, N.J.— 2023 年 1 月 4 日 — Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ(Nasdaq:CERT)は、CERT), today announced it has acquired Vyasa Analytics, LLC. Vyasa provides scalable deep-learning software which allows life sciences organizations to perform predictions and answer complex questions across structured and unstructured bio-medical information. The acquisition will elevate Certara’s software by bringing state-of-the-art artificial intelligence (AI) capabilities to its end-to-end platform.

“We are pleased to announce the acquisition of Vyasa, a cutting-edge company that will enhance existing Certara software platforms and further expand our capabilities across our product portfolios,” said William F. Feehery, Chief Executive Officer of Certara. “By incorporating AI into our suite of products, we are building capabilities that will continue to expand our leadership for biosimulation use cases in drug research and development.”

Formed in 2017, Vyasa software provides a novel AI-powered platform for organizations to integrate and analyze content across their entire enterprise data landscape. Vyasa’s leading product, LAYAR, a flexible and modular data fabric that evaluates quantitative data, text, and images, offers AI capabilities to support decisions in all phases of drug development.

Certara(サターラ) について
Certara accelerates medicines using proprietary biosimulation software, technology, and services to transform traditional drug discovery and development. 製薬、教育機関、規制当局のお客様 2,000人以上、6262ヵ国にてサターラの技術やサービスが活用されています。 

Forward Looking Statements

当プレスリリースには将来に関する記述が含まれます。These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. サターラの信条や予想に関する記述を含め、歴史的事実ではない記述は将来に関する記述に該当します。将来に関する記述には、本質的にリスクや不確実性が含まれます。また様々な要因により、実際の結果が将来に関する記述に含まれるそれとは大きく異なるものになる可能性があります。こうした要因には以下のものが含まれますが、これらに限定されるものではありません。(i) our ability to successfully integrate Vyasa into our existing organization; (ii) our ability to successfully integrate Vyasa products and technology into our existing products; (iii) our ability to retain key personnel from Vyasa or recruit additional qualified personnel; (iv) our ability to achieve operational synergies; (vi) our ability to demonstrate the benefits of combining Vyasa’s technology with our existing or new products and (vii) our ability to satisfy specific customer needs by combining Vyasa’s technology with our existing or new products. 将来に関する記述は、「だろう」「でしょう」「予定である」「予想される」「予測される」「目標とする」「目的とする」「推定される」「意図する」「計画する」「信じる」「可能性がある」「引き続き」「見込みである」やこれらに似た表現で特定できます。All information provided in this press release is as of the date of this press release, and Certara undertakes no duty to update such information, except as required under applicable law.

投資家の皆様:
David Deuchler
Gilmartin Group
ir@certara.com

報道機関の皆様:

赤津笑美 emi.akatsu@certara.com

サターラ合同会社

daniel.yunger@kekstcnc.com

Powered by Translations.com GlobalLink OneLink Software